Geode Capital Management, LLC Clovis Oncology, Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.85 $5,520 - $14,985	5,258 Added 0.38%	1,382,968 $1.65 Million
Q2 2022 Aug 12, 2022	SELL	$0.63 - $2.96 $452,962 - $2.13 Million	-718,988 Reduced 34.29%	1,377,710 $2.48 Million
Q1 2022 May 13, 2022	SELL	$1.43 - $3.14 $165,757 - $363,969	-115,914 Reduced 5.24%	2,096,698 $4.24 Million
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $518,510 - $914,115	192,041 Added 9.5%	2,212,612 $6 Million
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $705,782 - $1.01 Million	173,838 Added 9.41%	2,020,571 $9.01 Million
Q2 2021 Aug 13, 2021	BUY	$5.02 - $7.05 $935,682 - $1.31 Million	186,391 Added 11.23%	1,846,733 $10.7 Million
Q1 2021 May 12, 2021	BUY	$4.81 - $10.34 $1.49 Million - $3.2 Million	309,477 Added 22.91%	1,660,342 $11.7 Million
Q4 2020 Feb 12, 2021	BUY	$4.13 - $6.41 $79,490 - $123,373	19,247 Added 1.45%	1,350,865 $6.48 Million
Q3 2020 Nov 13, 2020	BUY	$4.82 - $7.72 $461,625 - $739,367	95,773 Added 7.75%	1,331,618 $7.76 Million
Q2 2020 Aug 13, 2020	BUY	$5.69 - $9.69 $1.82 Million - $3.1 Million	320,135 Added 34.96%	1,235,845 $8.34 Million
Q1 2020 May 14, 2020	BUY	$3.77 - $11.0 $746,942 - $2.18 Million	198,128 Added 27.61%	915,710 $5.82 Million
Q4 2019 Feb 13, 2020	BUY	$3.0 - $16.43 $2,754 - $15,082	918 Added 0.13%	717,582 $7.48 Million
Q3 2019 Nov 12, 2019	BUY	$3.93 - $15.35 $92,606 - $361,707	23,564 Added 3.4%	716,664 $2.82 Million
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $949,080 - $1.9 Million	74,089 Added 11.97%	693,100 $10.3 Million
Q1 2019 May 14, 2019	BUY	$17.66 - $30.28 $830,143 - $1.42 Million	47,007 Added 8.22%	619,011 $15.4 Million
Q4 2018 Feb 13, 2019	BUY	$11.63 - $32.67 $457,861 - $1.29 Million	39,369 Added 7.39%	572,004 $10.3 Million
Q3 2018 Nov 13, 2018	BUY	$29.37 - $49.48 $607,400 - $1.02 Million	20,681 Added 4.04%	532,635 $15.6 Million
Q2 2018 Aug 14, 2018	BUY	$42.06 - $62.4 $2.76 Million - $4.09 Million	65,557 Added 14.69%	511,954 $23.3 Million
Q1 2018 May 15, 2018	BUY	$50.12 - $67.72 $495,135 - $669,005	9,879 Added 2.26%	446,397 $23.6 Million
Q4 2017 Feb 13, 2018	BUY	$57.69 - $84.58 $69,574 - $102,003	1,206 Added 0.28%	436,518 $29.7 Million
Q3 2017 Nov 14, 2017	BUY	$67.17 - $84.81 $608,896 - $768,802	9,065 Added 2.13%	435,312 $35.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	426,247	426,247 $39.9 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account